「japan」の検索結果
79件：51～55件目を表示
-
f Licensing Agreement with Brill International Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces that it has entered into...
https://www.senju.co.jp/system/files/content_news/2025-03/ENG_20250307_0.pdf -
ion of Marketing Approval for “ Mytear LUMIFY” Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida) today announces that it has received approval for the marketin...
https://www.senju.co.jp/system/files/content_news/2024-08/ENG_20240903.pdf -
ion of Marketing Approval for “ Mytear LUMIFY” Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida) today announces that it has received approval for the marketin...
https://www.senju.co.jp/system/files/content_news/2024-08/ENG_20240903_0.pdf -
f Licensing Agreement with Brill International Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces that it has entered into...
https://www.senju.co.jp/system/files/content_news/2025-03/ENG_20250307.pdf -
千寿製薬株式会社
新闻 2026年08月20日 Senju initiated Phase III Clinical Trials in Japan for "SJP-0049" for the treatment of Allergic Conjunctivitis（PDF） 2026年06月01日 Launch of Distribution of 3in1Smart and SPM-700...
https://www.senju.co.jp/chinese/